Chengdu kelingyuan Pharmaceutical Technology Co., Ltd. is a wholly-owned subsidiary of xilingyuan Pharmaceutical Co., Ltd. Kelingyuan focuses on the research and development of innovative drugs. At present, the product pipeline includes six research projects in the treatment of gastrointestinal diseases, cancer and ophthalmic diseases. Among them, smp-100 has entered the phase I clinical trial, and smp-115 has entered the drug-forming research
Cattechtm of Xiling Lab source has collected many homogeneous catalysts of various types. Among them, the ligands and catalysts based on NHC (N-heterocyclic carbene) have abundant reserves and can be supplied in large quantities.
Business Affairs：email@example.comContact us